Cargando…

Acetyltransferases and tumour suppression

The acetyltransferase p300 was first identified associated with the adenoviral transforming protein E1A, suggesting a potential role for p300 in the regulation of cell proliferation. Direct evidence demonstrating a role for p300 in human tumours was lacking until the recentl publication by Gayther e...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, A C, Vousden, Karen H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138782/
https://www.ncbi.nlm.nih.gov/pubmed/11250715
http://dx.doi.org/10.1186/bcr63
_version_ 1782120491630198784
author Phillips, A C
Vousden, Karen H
author_facet Phillips, A C
Vousden, Karen H
author_sort Phillips, A C
collection PubMed
description The acetyltransferase p300 was first identified associated with the adenoviral transforming protein E1A, suggesting a potential role for p300 in the regulation of cell proliferation. Direct evidence demonstrating a role for p300 in human tumours was lacking until the recentl publication by Gayther et al, which strongly supports a role for p300 as a tumour suppressor. The authors identify truncating mutations associated with the loss or mutation of the second allele in both tumour samples and cell lines, suggesting that loss of p300 may play a role in the development of a subset of human cancers.
format Text
id pubmed-138782
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1387822003-02-27 Acetyltransferases and tumour suppression Phillips, A C Vousden, Karen H Breast Cancer Res Commentary The acetyltransferase p300 was first identified associated with the adenoviral transforming protein E1A, suggesting a potential role for p300 in the regulation of cell proliferation. Direct evidence demonstrating a role for p300 in human tumours was lacking until the recentl publication by Gayther et al, which strongly supports a role for p300 as a tumour suppressor. The authors identify truncating mutations associated with the loss or mutation of the second allele in both tumour samples and cell lines, suggesting that loss of p300 may play a role in the development of a subset of human cancers. BioMed Central 2000 2000-05-24 /pmc/articles/PMC138782/ /pubmed/11250715 http://dx.doi.org/10.1186/bcr63 Text en Copyright © 2000 Current Science Ltd
spellingShingle Commentary
Phillips, A C
Vousden, Karen H
Acetyltransferases and tumour suppression
title Acetyltransferases and tumour suppression
title_full Acetyltransferases and tumour suppression
title_fullStr Acetyltransferases and tumour suppression
title_full_unstemmed Acetyltransferases and tumour suppression
title_short Acetyltransferases and tumour suppression
title_sort acetyltransferases and tumour suppression
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138782/
https://www.ncbi.nlm.nih.gov/pubmed/11250715
http://dx.doi.org/10.1186/bcr63
work_keys_str_mv AT phillipsac acetyltransferasesandtumoursuppression
AT vousdenkarenh acetyltransferasesandtumoursuppression